Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - AMERICAN GENE ENGINEER CORP | ex31_2.htm |
| 10-Q - FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2016 - AMERICAN GENE ENGINEER CORP | f61516210q.htm |
| EX-32.1 - EXHIBIT 32.1 - AMERICAN GENE ENGINEER CORP | ex32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - AMERICAN GENE ENGINEER CORP | ex31_1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Gene Engineer Corp. (the "Company") on Form 10-Q for the quarter ended April 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Han-Chen Lin, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 17, 2016
|
/s/ Han-Chen Lin
|
|
|
Han-Chen Lin
Principal Financial Officer
|
This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.